← Open Payments lookup

PAMELA DUGANO - DAPHNIS: Open Payments

NPI 1982695037 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,096 in 97 payments from 15 companies in 2025. Trend: 2023 $2,487 · 2024 $2,057 · 2025 $2,096

Food & beverage: $2,096
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP36$804
Bayer Healthcare Pharmaceuticals Inc.14$391
GlaxoSmithKline, LLC.12$256
Amgen Inc.15$227
Indivior Inc.3$80
Lilly USA, LLC3$52
Corcept Therapeutics2$45
Novo Nordisk Inc2$39
Esperion Therapeutics, Inc.2$34
SANOFI-AVENTIS U.S. LLC2$34

Products named: FARXIGA, Kerendia, AIRSUPRA, TRELEGY ELLIPTA, OTEZLA, SUBLOCADE, MOUNJARO, BREZTRI.

Industry payments across TX — which companies pay providers there.